Since 2017, Angelini Pharma and TEHA worked collaboratively on the Headway Initiative: a platform promoting reflection, analysis, dialogue and comparison in the management of Brain Health across Europe.
Research presented in Brussels by Angelini Pharma and The European House - Ambrosetti highlights that one in two young Europeans report unmet needs for mental healthcare.
Every year, on October 10th, World Mental Health Day provides a great opportunity to increase awareness on mental health issues and underline the necessity of addressing these challenges on a global scale.
Research presented in Rome by Angelini Pharma and The European House - Ambrosetti highlights that almost 40% of people with epilepsy receive inadequate treatment.
Purple Day was born from the determination of a 7-year-old Canadian girl with epilepsy in 2008: a day that is now celebrated in more than 85 countries around the world every 26th of March.
The company has decided to join the #50MillionSteps campaign, inviting its employees to participate, with the goal of reaching 1 million steps.
The result of 2022 report presented in Brussels at European Parliament
New report on Mental Health presented on September 28th
Among neurological disorders, Epilepsy is the 4th most common in Europe, causing 1.3 million DALYs (Disability Adjusted Life Years), and 941,000 YLDs (Years of Life Lost -YLLs).
Lampi (Lightnings) is a short film by Italian director Paolo Santamaria. It is aimed at raising awareness about brain health and the stigma surrounding patients
Angelini Pharma’s global communication campaign to raise awareness on epilepsy
A disease awareness campaign promoted by Angelini Pharma
The COVID 19 pandemic has exacerbated gender-related challenges with its mental health consequences disproportionately affecting women, both at work and at home, according to the findings of the “Headway 2023 - Mental Health Index” launched today.
A disease awareness campaign promoted by Angelini Pharma
Harmonia Mentis Global